Literature DB >> 1423214

Dysregulation of strongyloidiasis: a new hypothesis.

R M Genta1.   

Abstract

Few other human parasites are associated with such a diverse spectrum of clinical manifestations as Strongyloides stercoralis, yet the basic biological behavior of this unusually versatile worm, particularly with respect to its ability to cause severe disseminated disease in certain hosts, is poorly understood. The current uncritical acceptance of the theory that cell-mediated immunity controls autoinfection has stifled research in other directions. After reviewing what is and is not known about the parasite's behavior in its host, this article explores some of the mechanisms that could be involved in the regulation of the parasite population. Taking the provocative viewpoint that the parasite, not the host, is mainly responsible for the maintenance of a balanced relationship between the two, I propose a new theory that corticosteroids may act on the intraintestinal larvae as molting hormones and directly promote the development of disseminated disease.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1423214      PMCID: PMC358253          DOI: 10.1128/CMR.5.4.345

Source DB:  PubMed          Journal:  Clin Microbiol Rev        ISSN: 0893-8512            Impact factor:   26.132


  97 in total

1.  Diagnostic implications of parasite-specific immune responses in immunocompromised patients with strongyloidiasis.

Authors:  R M Genta; R W Douce; P D Walzer
Journal:  J Clin Microbiol       Date:  1986-06       Impact factor: 5.948

2.  Granulomatous hepatitis due to Strongyloides stercoralis.

Authors:  A A Poltera; N Katsimbura
Journal:  J Pathol       Date:  1974-08       Impact factor: 7.996

3.  Hyperinfection syndrome with Strongyloides stercoralis.

Authors:  E Rivera; N Maldonado; E Vélez-García; A J Grillo; G Malaret
Journal:  Ann Intern Med       Date:  1970-02       Impact factor: 25.391

4.  Demonstration and partial characterization of parasite-specific immunoglobulin A responses in human strongyloidiasis.

Authors:  R M Genta; D F Frei; M J Linke
Journal:  J Clin Microbiol       Date:  1987-08       Impact factor: 5.948

5.  Specific IgE responses in human strongyloidiasis.

Authors:  J McRury; I T De Messias; P D Walzer; T Huitger; R M Genta
Journal:  Clin Exp Immunol       Date:  1986-09       Impact factor: 4.330

6.  Filaricidal effects of cyclosporin-A against Dipetalonema viteae in Mastomys natalensis.

Authors:  D Bout; A Haque; A Capron
Journal:  Trans R Soc Trop Med Hyg       Date:  1984       Impact factor: 2.184

7.  [Digestive manifestations of the acquired immunodeficiency syndrome (AIDS): study in 26 patients].

Authors:  E René; C Marche; B Régnier; A G Saimot; B Vittecoq; S Matheron; C Le Port; F Bricaire; A Bure; C Brun-Vezinet
Journal:  Gastroenterol Clin Biol       Date:  1985-04

8.  Chronic relapsing colitis due to Strongyloides stercoralis.

Authors:  A J Berry; E G Long; J H Smith; W K Gourley; D P Fine
Journal:  Am J Trop Med Hyg       Date:  1983-11       Impact factor: 2.345

9.  Specific allergic sensitization to Strongyloides antigens in human strongyloidiasis.

Authors:  R M Genta; E A Ottesen; R Poindexter; A A Gam; F A Neva; H B Tanowitz; M Wittner
Journal:  Lab Invest       Date:  1983-05       Impact factor: 5.662

10.  Clinical, immunological and epidemiological aspects of strongyloidiasis in an endemic area of Brazil.

Authors:  I T de Messias; F Q Telles; A C Boaretti; S Sliva; L M Guimarres; R M Genta
Journal:  Allergol Immunopathol (Madr)       Date:  1987 Jan-Feb       Impact factor: 1.667

View more
  32 in total

1.  Dexamethasone effects in the Strongyloides venezuelensis infection in a murine model.

Authors:  Eleuza R Machado; Daniela Carlos; Carlos A Sorgi; Simone G Ramos; Daniela I Souza; Edson G Soares; Julia M Costa-Cruz; Marlene T Ueta; David M Aronoff; Lúcia H Faccioli
Journal:  Am J Trop Med Hyg       Date:  2011-06       Impact factor: 2.345

2.  Non-oral treatment with ivermectin for disseminated strongyloidiasis.

Authors:  Dahlene N Fusco; Jennifer A Downs; Michael J Satlin; Meera Pahuja; Liz Ramos; Philip S Barie; Lawrence Fleckenstein; Henry W Murray
Journal:  Am J Trop Med Hyg       Date:  2010-10       Impact factor: 2.345

3.  Evaluation of an indirect immunofluorescence assay for strongyloidiasis as a tool for diagnosis and follow-up.

Authors:  Marina Boscolo; Maria Gobbo; William Mantovani; Monica Degani; Mariella Anselmi; Geraldo Badona Monteiro; Stefania Marocco; Andrea Angheben; Manuela Mistretta; Maria Santacatterina; Stefano Tais; Zeno Bisoffi
Journal:  Clin Vaccine Immunol       Date:  2006-11-29

4.  Strongyloides stercoralis infection in a patient with Crohn's disease.

Authors:  L Pasqualini; D Crotti; A Scarponi; G Vaudo; E Mannarino
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1997-05       Impact factor: 3.267

Review 5.  Molecular testing for clinical diagnosis and epidemiological investigations of intestinal parasitic infections.

Authors:  Jaco J Verweij; C Rune Stensvold
Journal:  Clin Microbiol Rev       Date:  2014-04       Impact factor: 26.132

6.  Methylprednisolone acetate induces, and Δ7-dafachronic acid suppresses, Strongyloides stercoralis hyperinfection in NSG mice.

Authors:  John B Patton; Sandra Bonne-Année; Jessica Deckman; Jessica A Hess; April Torigian; Thomas J Nolan; Zhu Wang; Steven A Kliewer; Amy C Durham; James J Lee; Mark L Eberhard; David J Mangelsdorf; James B Lok; David Abraham
Journal:  Proc Natl Acad Sci U S A       Date:  2017-12-04       Impact factor: 11.205

7.  [Heavy diarrhea by low malignant B cell lymphoma].

Authors:  D Apel; R Jakobs; J Lugauer; U Höffler; M H Bohrer; J F Riemann
Journal:  Internist (Berl)       Date:  2004-09       Impact factor: 0.743

8.  Alcoholism and Strongyloides stercoralis: daily ethanol ingestion has a positive correlation with the frequency of Strongyloides larvae in the stools.

Authors:  Carla Couzi Marques; Maria da Penha Zago-Gomes; Carlos Sandoval Gonçalves; Fausto Edmundo Lima Pereira
Journal:  PLoS Negl Trop Dis       Date:  2010-06-22

9.  Endoscopic and histopathological study on the duodenum of Strongyloides stercoralis hyperinfection.

Authors:  Kazuto Kishimoto; Akira Hokama; Tetsuo Hirata; Yasushix Ihama; Manabu Nakamoto; Nagisa Kinjo; Fukunori Kinjo; Jiro Fujita
Journal:  World J Gastroenterol       Date:  2008-03-21       Impact factor: 5.742

Review 10.  Strongyloides stercoralis in the Immunocompromised Population.

Authors:  Paul B Keiser; Thomas B Nutman
Journal:  Clin Microbiol Rev       Date:  2004-01       Impact factor: 26.132

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.